Buscar

01/01/2022 Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
Valle-Tamayo N., Pérez-González R., Chiva-Blanch G., Belbin O., Serrano-Requena S., Sirisi S., González A.C., Giró O., Sánchez-Aced É., Dols-Icardo O., Alcolea D., Carmona-Iragui M., Jimenez A., Lleó A., Fortea J., Iulita M.F.. Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma. Jove-Journal of Visualized Experiments. 2022; 2022(186)DOI:10.3791/64107. PMID:35993755. IF:1.200(Q3/8D).
01/01/2022 Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
Ali M., Sung Y.J., Wang F., Fernández M.V., Morris J.C., Fagan A.M., Blennow K., Zetterberg H., Heslegrave A., Johansson P.M., Svensson J., Nellgård B., Lleó A., Alcolea D., Clarimon J., Rami L., Molinuevo J.L., Suárez-Calvet M., Morenas-Rodríguez E., Kleinberger G., Haass C., Ewers M., Levin J., Farlow M.R., Perrin R.J., Cruchaga C.. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk. PLoS One. 2022; 17DOI:10.1371/journal.pone.0267298. PMID:35617280. IF:3.700(Q2/4D).
01/01/2022 Smoking is associated with age at disease onset in Parkinson's disease
Rosas I., Morís G., Coto E., Blázquez-Estrada M., Suárez E., García-Fernández C., Martínez C., Herrera I.D., Pérez-Oliveira S., Álvarez V., Menéndez-González M., Adarmes-Gómez A.D., Aguilar M., Alvarez I., Barrero F.J., Bergareche Yarza J.A., Bonilla-Toribio M., Botía J.A., Boungiorno M.T., Buiza-Rueda D., Cámara A., Carrillo F., Cerdan D., Clarimón J., Compta Y., Diez-Fairen M., Dols-Icardo O., de Fabregues O., Cartagena P.S., Duarte J., Duran R., Escamilla-Sevilla F., Ezquerra M., Feliz C., Fernández-Santiago R., Fernández M., García-Ruiz P., Gómez-Garre P., Gomez Heredia M.J., Gonzalez-Aramburu I., Gorostidi A., Hoenicka J., Infante J., Jesús S., Jimenez-Escrig A., Kulisevsky J., Labrador-Espinosa M.A., Lopez-Sendon J.L., López de Munain A., Macias-Garcia D., Martínez-Torres I., Marín J., Marti M.J., Martínez-Castrillo J.C., Álvarez-Santullano M.M., Mínguez-Castellanos A., Mir P., Rezola E.M., Muñoz E., Pagonabarraga J., Pastor P., Errazquin F.P., Periñán M.T., Ruiz-Martínez J., Ruz C., Rodriguez A.S., Sierra M., Tabernero C., Tartari J.P., Tolosa E., Valldeoriola F., Vela L., Vives F., Pascual-Sedano B., Hernández-Vara J., Rolán D.V., Bandrés-Ciga S.. Smoking is associated with age at disease onset in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 97DOI:10.1016/j.parkreldis.2022.03.005. PMID:35364453. IF:4.100(Q2/3D).
01/12/2025 Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
Puerta, R, de Rojas, I, García-González, P, Olivé, C, Sotolongo-Grau, O, García-Sánchez, A, García-Gutiérrez, F, Montrreal, L, Tartari, JP, Sanabria, A, Pytel, V, Lage, C, Quintela, I, Aguilera, N, Rodriguez-Rodriguez, E, Alarcón-Martín, E, Orellana, A, Pastor, P, Pérez-Tur, J, Piñol-Ripoll, G, de Munain, AL, García-Alberca, JM, Royo, JL, Bullido, MJ, Alvarez, V, Real, LM, Anchuelo, AC, Gómez-Garre, D, Larrad, MTM, Franco-Macías, E, Mir, P, Medina, M, Sánchez-Valle, R, Dols-Icardo, O, Sáez, ME, Carracedo, A, Tárraga, L, Alegret, M, Valero, S, Marquié, M, Boada, M, Juan, PS, Cavazos, JE, Cabrera-Socorro, A, Cano, A, Ruiz, A, Alzheimers Dis Neuroimaging Initiative. Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO. FUNCTIONAL & INTEGRATIVE GENOMICS. 2025; 25(1)DOI:10.1007/s10142-025-01581-6. PMID:40133566. IF:3.100(Q2/4D).
15/11/2025 Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men
Sauter, C, Dorn, H, Bueno-Lopez, A, Eggert, T, Schmid, G, Danker-Hopfe, H. Effects of radiofrequency electromagnetic fields on cognitive function in elderly subjects (60+years)-Results of an experimental randomized sham controlled double-blind cross-over study in women and in men. ENVIRONMENTAL RESEARCH. 2025; 285DOI:10.1016/j.envres.2025.122479. PMID:40744201. IF:7.700(Q1/1D).
02/09/2025 An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease
Fortea, J, Ferrer-Picón, E. An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease. Expert Review of Neurotherapeutics. 2025; 25(9)DOI:10.1080/14737175.2025.2527211. PMID:40600688. IF:3.400(Q2/3D).
01/08/2025 Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease
Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).
22/07/2025 CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients
Oosthoek, M, Vijverberg, EGB, Blujdea, ER, Veld, SGJGI, Avilés, MP, Zsadanyi, SE, Hok-A-Hin, YS, Visser, A, van der Flier, WM, Barkhof, F, del Campo, M, Schut, MC, Bejanin, A, Alcolea, D, Teunissen, CE, Vermunt, L. CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01799-3. PMID:40696469. IF:7.600(Q1/1D).
05/07/2025 Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic
Arranz, J, Ferrer, R, Zhu, NL, Rubio-Guerra, S, Rodríguez-Baz, I, Arriola-Infante, JE, Maure-Blesa, L, Garcia-Castro, J, Selma-González, J, Carmona-Iragui, M, Barroeta, I, Illán-Gala, I, Santos-Santos, M, Fortea, J, Lleó, A, Tondo, M, Alcolea, D. Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic. Alzheimers Research & Therapy. 2025; 17(1)DOI:10.1186/s13195-025-01779-7. PMID:40618130. IF:7.600(Q1/1D).
03/07/2025 Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder
Pardo, J, Roura, I, Montal, V, Martin-Barcelo, C, Oltra, J, Campabadal, A, Bargallo, N, Serradell, M, Maya, G, Montini, A, Gaig, C, Pont-Sunyer, C, Fortea, J, Iranzo, A, Junqué, C, Segura, B. Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-01058-0. PMID:40610447. IF:8.200(Q1/1D).
01/07/2025 Comparative performance of plasma pTau181/Aß42 , pTau217/Aß42 ratios, and individual measurements in detecting brain amyloidosis
Lehmann, S, Gabelle, A, Duchiron, M, Busto, G, Morchikh, M, Delaby, C, Hirtz, C, Mondesert, E, Cristol, JP, Barnier-Figue, G, Perrein, F, Jurici, S, Bennys, K. Comparative performance of plasma pTau181/Aß42 , pTau217/Aß42 ratios, and individual measurements in detecting brain amyloidosis. EBioMedicine. 2025; 117DOI:10.1016/j.ebiom.2025.105805. PMID:40513421. IF:10.800(Q1/1D).
01/07/2025 Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
Nicolas, A, Sherva, R, Grenier-Boley, B, Kim, Y, Kikuchi, M, Timsina, J, de Rojas, I, Dalmasso, MC, Zhou, XP, Le Guen, Y, Arboleda-Bustos, CE, Bicalho, MAC, Guerchet, M, van der Lee, S, Goss, M, Castillo, A, Bellenguez, C, Küçükali, F, Satizabal, CL, Fongang, B, Yang, Q, Peters, O, Schneider, A, Dichgans, M, Rujescu, D, Scherbaum, N, Deckert, J, Riedel-Heller, S, Hausner, L, Molina-Porcel, L, Duezel, E, Grimmer, T, Wiltfang, J, Heilmann-Heimbach, S, Moebus, S, Tegos, T, Scarmeas, N, Dols-Icardo, O, Moreno, F, Pérez-Tur, J, Bullido, MJ, Pastor, P, Sánchez-Valle, R, Alvarez, V, Cao, H, Ip, NY, Fu, AKY, Ip, FCF, Olivar, N, Muchnik, C, Cuesta, C, Campanelli, L, Solis, P, Politis, DG, Kochen, S, Brusco, LI, Boada, M, García-González, P, Puerta, R, Mir, P, Real, LM, Pinol-Ripoll, G, García-Alberca, JM, Royo, JL, Rodriguez-Rodriguez, E, Soininen, H, Heikkinen, S, de Mendonça, A, Mehrabian, S, Traykov, L, Hort, J, Vyhnalek, M, Rasmussen, KL, Thomassen, JQ, Pijnenburg, YAL, Holstege, H, van Swieten, JC, Seelaar, H, Claassen, JAHR, Jansen, WJ, Ramakers, I, Verhey, F, van der Lugt, A, Scheltens, P, Ortega-Rojas, J, Mera, AGC, Mahecha, MF, Pardo, R, Arboleda, G, Bahrami, S, Fominykh, V, Selbaek, G, Graff, C, Papenberg, G, Giedraitis, V, Boland, A, Deleuze, JF, de Marco, LA, de Moraes, EN, Viana, BD, Cintra, MTG, Juarez-Cedillo, T, Griswold, AJ, Forund, T, Haines, J, Farrer, L, Destefano, A, Wijsman, E, Mayeux, R, Pericak-Vance, M, Kunkle, B, Goate, A, Schellenberg, GD, Vardarajan, B, Wang, LS, Leung, YY, Dalgard, CL, Nicolas, G, Wallon, D, Dufouil, C, Pasquier, F, Hanon, O, Debette, S, Gruenblatt, E, Popp, J, Angel, B, Gloger, S, Chacon, MV, Aranguiz, R, Orellana, P, Slachevsky, A, Gonzalez-Billault, C, Albala, C, Fuentes, P, Sachdev, P, Mather, KA, Hauger, RL, Merritt, V, Panizzon, M, Zhang, R, Gaziano, JM, Ghidoni, R, Galimberti, D, Arosio, B, Mecocci, P, Solfrizzi, V, Parnetti, L, Squassina, A, Tremolizzo, L, Borroni, B, Nacmias, B, Caffarra, P, Seripa, D, Rainero, I, Daniele, A, Piras, F, Leonard, HL, Yokoyama, JS, Nalls, MA, Miyashita, A, Hara, N, Ozaki, K, Niida, S, Williams, J, Masullo, C, Amouyel, P, Preux, PM, Mbelesso, P, Bandzouzi, B, Saykin, A, Jessen, F, Kehoe, PG, Van Duijn, C, Ben Salem, N, Frikke-Schmidt, R, Cherni, L, Greicius, MD, Tsolaki, M, Sánchez-Juan, P, Silva, MAR, Porter, T, Laws, SM, Sleegers, K, Ingelsson, M, Dartigues, JF, Seshadri, S, Rossi, G, Morelli, L, Hiltunen, M, Sims, R, van der Flier, W, Andreassen, OA, Arboleda, H, Cruchaga, C, Escott-Price, V, Ruiz, A, Lee, KH, Ikeuchi, T, Ramirez, A, Gim, J, Logue, M, Lambert, JC. Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations. NATURE GENETICS. 2025; 57(7)DOI:10.1038/s41588-025-02227-w. PMID:40533518. IF:29.000(Q1/1D).
01/06/2025 Democratizing dementia research through global online conferences
Zsadanyi, SE, Addison, E, Alladi, S, Andrews, SJ, Keerthana, BS, Carello-Collar, G, Dubljevic, O, Ehrenberg, AJ, Farina, FR, Grinberg, LT, Ibáñez, A, Martersteck, A, Nigussie, A, Rogalski, EJ, Seibert, K, Stefanova, E, Yaffe, K, Zewde, YZ, Zimmer, ER, Fontana, IC, Sexton, CE. Democratizing dementia research through global online conferences. NATURE NEUROSCIENCE. 2025; 28(6)DOI:10.1038/s41593-025-01949-8. PMID:40325214. IF:20.000(Q1/1D).
01/06/2025 Use of Multiple Languages Provides Cognitive Reserve Amidst Age-Related White Matter Changes
Solé-Padullés, C, Cattaneo, G, Cabello-Toscano, M, Mulet-Pons, L, Vaqué-Alcázar, L, Roca-Ventura, A, Alviarez-Schulze, V, Bargalló, N, Solana-Sánchez, J, Pascual-Leone, A, Bartrés-Faz, D. Use of Multiple Languages Provides Cognitive Reserve Amidst Age-Related White Matter Changes. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2025; 80(6)DOI:10.1093/geronb/gbaf064. PMID:40197522. IF:3.200(Q1/1D).
30/05/2025 SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model
Lioudyno, MI, Sevrioukov, EA, Olivarria, GM, Hitchcock, L, Javonillo, DI, Campos, SM, Rivera, I, Wright, ST, Head, E, Fortea, J, Wisniewski, T, Cuello, AC, Do Carmo, S, Lane, TE, Busciglio, J. SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model. ACTA NEUROPATHOLOGICA. 2025; 149(1)DOI:10.1007/s00401-025-02895-2. PMID:40445428. IF:9.300(Q1/1D).
24/05/2025 Regulatory asymmetry in Alzheimer's disease care
Fortea, J, Boban, M, Engelborghs, S, Frederiksen, KS, Hort, J, Kennelly, S, Kramberger, MG, Mehrabian, S, Plantone, D, Paquet, C, Santana, I, Scarmeas, N, Solje, E, Spiru, L, Sutovsky, S, Vijverberg, EGB, Winblad, B, Jessen, F. Regulatory asymmetry in Alzheimer's disease care. LANCET. 2025; 405(10492)DOI:10.1016/S0140-6736(25)00907-9. PMID:40381642. IF:88.500(Q1/1D).
09/05/2025 Reduced blood EPAC1 protein levels as a marker of severe coronary artery disease: the role of hypoxic foam cell-transformed smooth muscle cells
Garcia, E, Claudi, L, Lhoëst, MTL, Polishchuk, A, Samouillan, V, Amaro, AB, Pinero, J, Escolà-Gil, JC, Sabidó, E, Leta, R, Vilades, D, Cortes, VL. Reduced blood EPAC1 protein levels as a marker of severe coronary artery disease: the role of hypoxic foam cell-transformed smooth muscle cells. Journal of Translational Medicine. 2025; 23(1)DOI:10.1186/s12967-025-06513-3. PMID:40346550. IF:7.500(Q1/2D).
01/05/2025 LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria
Benitez-Amaro, A, Garcia, E, Lhoëst, MTL, Polishchuk, A, Zegri-Reiriz, I, Vilades, D, Guerra, JM, Fernández-del-Rio, L, Mirabet, S, Samouillan, V, Shirihai, O, Liesa, M, Enrich, C, Llorente-Cortés, V. LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria. JOURNAL OF LIPID RESEARCH. 2025; 66(5)DOI:10.1016/j.jlr.2025.100783. PMID:40122209. IF:4.100(Q2/4D).
01/05/2025 Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD
Gonzalez, MC, Oftedal, L, Lange, J, Tovar-Rios, DA, Tysnes, OB, Paquet, C, Marquie, M, Boada, M, Alcolea, D, Rejdak, K, Papuc, E, Hort, J, Falup-Pecurariu, C, Aarsland, D, Alves, G, Maple-Grodem, J. Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PD. Annals of Clinical and Translational Neurology. 2025; 12(5)DOI:10.1002/acn3.52295. PMID:40051075. IF:3.900(Q1/3D).
05/04/2025 Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures
Macías, M, Alba-Linares, JJ, Acha, B, Blanco-Luquin, I, Fernández, AF, Alvarez-Jiménez, J, Urdánoz-Casado, A, Roldan, M, Robles, M, Cabezon-Arteta, E, Alcolea, D, de Gordoa, JSR, Corroza, J, Cabello, C, Erro, ME, Jericó, I, Fraga, MF, Mendioroz, M. Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(7)DOI:10.3390/ijms26073419. PMID:40244264. IF:4.900(Q1/3D).